MessageAmp™ II aRNA Amplification Kit

(Part Number AM1751)

Protocol

I. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
A. Product Description and Background
B. Procedure Overview
C. Materials Provided with the Kit and Storage Conditions
D. Materials Not Provided with the Kit
E. Related Products Available from Invitrogen
II. aRNA Amplification Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
A. Important Parameters for Successful Amplification
B. Prepare the Wash Buffer
C. Reverse Transcription to Synthesize First Strand cDNA
D. Second Strand cDNA Synthesis
E. cDNA Purification
F. In Vitro Transcription to Synthesize aRNA
G. aRNA Purification
III. Assessing aRNA Yield and Quality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
A. aRNA Quantitation and Expected Yield
B. Analysis of aRNA Size
IV. (Optional) Second Round Amplification. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
A. Synthesis of First Strand cDNA (Second Round)
B. Synthesis of Second Strand cDNA (Second Round)
V. Troubleshooting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
A. Positive Control Reaction
B. Factors that Affect Both the Positive Control and Experimental Samples
C. Troubleshooting Low Yield and Small Average aRNA Size
D. aRNA is Not Efficiently Reverse Transcribed
VI. Appendix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
A. References
B. Quality Control
C. Safety Information
 P/N 1751M Revision C Revision Date: October 29, 2009

For research use only. Not for use in diagnostic procedures.

Information in this document is subject to change without notice. Ambion, a part of Life Technologies Corporation,
assumes no responsibility for any errors that may appear in this document. Ambion disclaims all warranties with
respect to this document, expressed or implied, including but not limited to those of merchantability or fitness for a
particular purpose. In no event shall Ambion be liable, whether in contract, tort, warranty, or under any statute or on
any other basis for special, incidental, indirect, punitive, multiple or consequential damages in connection with or
arising from this document, including but not limited to the use thereof.
Literature Citation: When describing a procedure for publication using this product, please refer to it as the
MessageAmp™ II aRNA Amplification Kit.
Warranty and Liability: Ambion, a part of Life Technologies Corporation, is committed to delivering superior
product quality and performance, supported by industry-leading global service and technical support teams. War-
ranty information for the accompanying consumable product is available at www.ambion.com/info/warranty in
“Limited Warranty for Consumables,” which is subject to the exclusions, conditions, exceptions, and limitations set
forth under the caption “EXCLUSIONS, CONDITIONS, EXCEPTIONS, AND LIMITATIONS” in the full war-
ranty statement. Please contact Ambion if you have any questions about our warranties or would like information
about post-warranty support.
Patents and Licensing Notifications: The MessageAmp™ II aRNA Amplification Kit is covered by US pat-
ents 5256555, 6586218, and 6586219.
Trademarks: Trademarks of Life Technologies Corporation and its affiliated companies: Applied Biosystems®,
AB (Design)®, Ambion®, ArrayControl™, ArrayScript™, FirstChoice®, GLOBINclear™, MEGAclear™, MEGAscript®,
MessageAmp™, RETROscript®, Ribogreen®, and RNaseZap®. Cy and CyDye are trademarks of GE Healthcare. All
other trademarks are the sole property of their respective owners.
© 2009 Life Technologies Corporation. All Rights Reserved.
MA2_AM1751_PrtclChange_revC.fm Page 1 Thursday, October 29, 2009 2:16 PM

Revised Protocol:
Ambion, a part of Life Technologies Corporation, is committed to
producing the highest quality reagents and kits. As part of that
commitment, the MessageAmp™ II aRNA Amplification Kit protocol
has been revised.

The protocol changes, summarized below, affect multiple steps; please review
the revised protocol carefully.

A thermal cycler with a temperature-adjustable lid is recommended for all

reaction incubations. For customers who have thermal cyclers with static
heated lids, or who lack access to a thermal cycler, alternative conditions are
provided.

In the reverse transcription step (section II.C), annealing of the RNA with
with T7 Oligo(dT) Primer at 70°C is no longer required.

The cDNA elution is performed with 18 μL of 55°C Nuclease-free Water

(step II.E.5).

The aRNA elution step (step II.G.6) is performed with 200 μL of 55°C
Nuclease-free Water, and a 10 min incubation at 55°C is recommended for
improved aRNA recovery.

These changes result in higher and more consistent nucleic acid yields and
quality, using a more convenient procedure.
 Introduction

I. Introduction

A. Product Description and Background

The MessageAmp™ II aRNA Amplification Kit (patent pending) is
based on the RNA amplification protocol developed in the Eberwine
laboratory (Van Gelder et al. 1990). The procedure consists of reverse
transcription with an oligo(dT) primer bearing a T7 promoter using
ArrayScript™ reverse transcriptase (RT; patent pending), engineered to
produce higher yields of first-strand cDNA than wild-type enzymes.
ArrayScript RT catalyzes the synthesis of virtually full-length cDNA,
which is the best way to ensure production of reproducible microarray
samples. The cDNA then undergoes second-strand synthesis and
cleanup to become a template for in vitro transcription (IVT) with
T7 RNA polymerase. To maximize aRNA yield, Ambion MEGAscript®
IVT technology is used to generate hundreds to thousands of antisense
RNA copies of each mRNA in a sample. (In this protocol the antisense
amplified RNA is referred to as aRNA; it is also commonly called
cRNA.) The IVT can be configured to synthesize either biotin-labeled
RNA, or unlabeled aRNA that can subsequently be labeled by reverse
transcription (for example with fluorescently labeled dNTPs).
The resulting aRNA is suitable for use on most commercially available
microarray gene expression systems. RNA samples of limited amounts
(0.1–100 ng) can be put through two rounds of amplification if desired.
This strategy makes the production of microarray samples from picogram
amounts of total RNA entirely possible (Luo et al. 1999).

Benefits of RNA RNA amplification was originally developed as a method to expand very
amplification small RNA samples to produce enough material for array hybridization
(Yue et al. 2001). Several groups have conducted studies to determine
whether amplification of RNA introduces bias and they report that any
bias is minimal (Li et al. 2004, Feldman et al. 2002 and Polacek et al.
2003). Additionally, among the benefits of amplification is a more
reproducible expression profile from a wide range of RNA inputs. Some
researchers conclude that amplification actually improves the reliability
of array results regardless of whether it is needed for sample expansion
(Feldman et al. 2002 and Polacek et al. 2003). As a result, RNA ampli-
fication has become the standard method for preparing RNA samples
for array analysis (Kacharmina et al. 1999, Pabon et al. 2001).

I.A. Product Description and Background 1

 MessageAmp™ II aRNA Amplification Kit

Figure 1. MessageAmp™ II aRNA Amplification Procedure

Reverse Transcription to Synthesize First Strand cDNA

5' AAAA 3'
Total RNA TTTT-T7
1. Adjust RNA sample volume to 10 μL, if necessary
+ TTTT-T7
TTTT-T7 2. Add 10 μL of Reverse Transcription Master Mix and place at 42°C
T7 Oligo(dT) Primer
3. Incubate for 2 hr at 42°C
2 hr

5' AAAA–3'
3' TTTT-T7–5'
cDNA
Second Strand cDNA Synthesis

2 hr 1. Add 80 μL Second Strand Master Mix to each sample

2. Incubate for 2 hr at 16°C
5' AAAA-T7–3'
3' TTTT-T7–5' Potential stopping point
dsDNA transcript

cDNA Purification
1. Preheat Nuclease-free Water to 55°C
2. Add 250 μL cDNA Binding Buffer to each sample
enzymes
salts
20 min 3. Pass the mixture through a cDNA Filter Cartridge
RNAs 4. Wash with 500 μL Wash Buffer
excess primers
5. Elute cDNA with 18 μL 55°C Nuclease-free Water
5' AAAA-T7–3' Potential stopping point
3' TTTT-T7–5'
dsDNA transcription template

In Vitro Transcription to Synthesize aRNA

1a. For 20 μL IVT reactions, concentrate the cDNA
4–14 hr
1b. For 40 μL IVT reactions, proceed directly to step 2
2. Add IVT Master Mix to each sample, and mix
3' UUUU–5'
3' UUUU–5' 3. Incubate 4–14 hr at 37°C
3' UUUU–5' 4. Add Nuclease-free Water to bring each sample to 100 μL
3' UUUU–5'

antisense RNA (aRNA) Potential stopping point

aRNA Purification

1. Preheat Nuclease-free Water and assemble Filter Cartridges and Tubes

20 min 2. Add 350 μL aRNA Binding Buffer to each sample
enzymes 3. Add 250 μL 100% ethanol and pipet 3 times to mix
salts
4. Pass samples through an aRNA Filter Cartridge
unused NTPs
5. Wash with 650 μL Wash Buffer
3' UUUU–5' 6. Elute aRNA with 200 μL 55°C Nuclease-free Water
3' UUUU–5'
3' UUUU–5' Potential stopping point
3' UUUU–5'

aRNA is ready for hybridization or labeling

by reverse transcription

2 I.A. Product Description and Background

 Introduction

B. Procedure Overview
The MessageAmp II aRNA amplification procedure is depicted in
Figure 1.
• Reverse Transcription to Synthesize First Strand cDNA is primed
with the T7 Oligo(dT) Primer to synthesize cDNA containing a T7
promoter sequence.
• Second Strand cDNA Synthesis converts the single-stranded cDNA
into a double-stranded DNA (dsDNA) template for transcription.
The reaction employs DNA Polymerase and RNase H to simultane-
ously degrade the RNA and synthesize second-strand cDNA.
• cDNA Purification removes RNA, primers, enzymes, and salts that
would inhibit in vitro transcription.
• In Vitro Transcription to Synthesize aRNA generates multiple cop-
ies of aRNA from the double-stranded cDNA templates; this is the
amplification step.
• aRNA Purification removes unincorporated NTPs, salts, enzymes,
and inorganic phosphate to improve the stability of the aRNA and to
facilitate subsequent enzymatic reactions.

Optional second round of Additional amplification of an RNA sample can be achieved by subject-
amplification ing the aRNA to a second round of amplification (see Figure 2). The
reagents and methodology used in the first and second rounds of ampli-
fication are only slightly different (see section IV starting on page 25.)
Figure 2. Second Round Amplification
aRNA from 1st round
of amplification

5'–UUUU 3'
Reverse Transcription with Second Round Primers

5'–UUUU 3'
3'–AAAA 5'
T7-TTTT Digestion with RNase H
T7-TTTT Second strand synthesis with T7 Oligo(dT) Primer

5'–T7-TTTT 3'
3'–AAAA 5'
cDNA purification
in vitro transcription (amplification)

5'–UUUU 3'

5'–UUUU 3'
5'–UUUU 3'

5'–UUUU 3'

aRNA purification

I.B. Procedure Overview 3

 MessageAmp™ II aRNA Amplification Kit

The MessageAmp II Each step in the MessageAmp II aRNA Amplification Kit amplification
advantage procedure has been streamlined and optimized. The first-strand cDNA
synthesis reaction employs ArrayScript reverse transcriptase to ensure
that every cDNA bears a T7 promoter at its 5' end and that even very
limited amounts of mRNA are fully converted to full-length cDNA.
The second-strand cDNA synthesis reaction is designed for the efficient
synthesis of full-length, double-stranded cDNAs and the complete con-
version of single-stranded cDNA into double-stranded transcription
templates. The cDNA purification procedure not only removes
enzymes, salts, and unincorporated dNTPs, but also efficiently removes
RNA from the cDNA sample. This eliminates the heating or enzymatic
digestion step commonly used in other procedures to degrade RNA
(especially ribosomal RNA). The IVT reaction features MEGAscript
technology to maximize transcriptional amplification and yield of
aRNA. It is optimized to ensure efficient transcription of limited
amounts of input DNA and synthesis of long transcripts.
The NTPs for IVT are provided separately so that modified nucleotides
(e.g., biotinylated UTP, or cyanine 3/cyanine 5 CTP and UTP) can be
readily incorporated into aRNA. The simple, rapid aRNA purification
procedure prepares the aRNA for downstream applications (reverse
transcription or post-labeling reactions).

C. Materials Provided with the Kit and Storage Conditions

The MessageAmp II aRNA Amplification Kit includes reagents for
single-round amplification of 20 samples or two-round amplification of
10 samples.
cDNA synthesis and IVT Do not store reagents in a frost-free freezer.
reagents Amount Component Storage
60 μL T7 Oligo(dT) Primer* –20°C
22 μL ArrayScript™ Reverse Transcriptase –20°C
22 μL RNase Inhibitor –20°C
42 μL 10X First Strand Buffer –20°C
170 μL dNTP Mix –20°C
210 μL 10X Second Strand Buffer –20°C
42 μL DNA Polymerase –20°C
22 μL RNase H –20°C
84 μL T7 Enzyme Mix –20°C
84 μL T7 10X Reaction Buffer –20°C
84 μL T7 ATP –20°C

4 I.C. Materials Provided with the Kit and Storage Conditions

 Introduction

Amount Component Storage

84 μL T7 CTP –20°C
84 μL T7 GTP –20°C
84 μL T7 UTP –20°C
40 μL Second Round Primers –20°C
10 μL Control RNA (1 mg/mL HeLa total RNA) –20°C
1.75 mL Nuclease-free Water any temp†
* The T7 Oligo(dT) Primer is available separately from Ambion (P/N AM5710).
† Store the Nuclease-free Water at –20°C, 4°C, or room temperature.

Some reagents may form a precipitate when stored at –20°C. If a precip-

itate is visible, redissolve it by warming the solution to room tempera-
ture with gentle mixing.

cDNA and aRNA purification Do not store reagents in a frost-free freezer.

Amount Component Storage
30 mL Wash Buffer (Add 24 mL 100% ethanol before use) 4°C or room temp
7 mL cDNA Binding Buffer room temp*
9 mL aRNA Binding Buffer room temp
20 aRNA Filter Cartridges room temp
40 aRNA Collection Tubes room temp
20 cDNA Filter Cartridges + Tubes room temp
20 cDNA Elution Tubes room temp
10 mL Nuclease-free Water any temp†
* The cDNA Binding Buffer may form a precipitate if stored colder than room tem-
perature. If a precipitate is visible, redissolve it by warming the solution to 37°C for
up to 10 min and vortexing vigorously. Cool to room temperature before use.
† Store the Nuclease-free Water at –20°C, 4°C, or room temperature.

D. Materials Not Provided with the Kit

Lab equipment and supplies • 100% Ethanol (to prepare the Wash Buffer)
• Thermal cycler with adjustable-temperature heated-lid (recom-
mended), hybridization oven, or constant temperature incubators set
at 70°C, 42°C, 37°C, and 16°C (See Thermal cycler recommended on
page 11 for more information.)
• Heat block set at 55°C, for preheating the water for cDNA and
aRNA purification
• Vacuum centrifuge concentrator
• Vortex mixer
• Microcentrifuge
• Non-stick RNase-free 0.5 mL microcentrifuge tubes (Ambion
P/N AM12350)

I.D. Materials Not Provided with the Kit 5

 MessageAmp™ II aRNA Amplification Kit

• RNase-free pipettors and tips, positive-displacement type recom-

mended to increase the accuracy and precision of reaction inputs
• (Optional) RNA controls for microarrays analysis, such as Array
Control™ RNA Spikes from Ambion (P/N AM1780) or the
GeneChip® Eukaryotic Poly-A RNA Control Kit from Affymetrix®
(Cat #900433)
• (Optional) Non-stick RNase-free tubes for storage of cDNA (e.g.,
AM12450)

Optional materials and • Spectrophotometer—such as the NanoDrop ND-1000 or ND-8000

equipment for RNA analysis UV-Vis Spectrophotometer. Follow the manufacturer’s instructions.
• (Optional) Agilent bioanalyzer and RNA LabChip Kits
• (Optional) Reagents and apparatus for preparation and electropho-
resis of agarose gels
• (Optional) RiboGreen® RNA Quantitation Assay and Kit (Molecu-
lar Probes Inc.)

(Optional) Biotin-labeled Biotin-labeled UTP can be added to the in vitro transcription reaction
UTP to synthesize biotin-labeled aRNA. Biotin-11-UTP (P/N AM8451,
75 mM) is recommended because it gives good incorporation, has min-
imal effect on aRNA recovery during purification, and results in high
signal on most commercial microarrays. Biotin-16-UTP (Ambion
P/N AM8453, 75 mM) can also be used if it suits your experimental
needs.

E. Related Products Available from Invitrogen

MessageAmp™ aRNA A full line of Ambion® MessageAmp Kits is available, tailored for different
Amplification Kits array analysis applications. The MessageAmp II Kit offers maximum flexibil-
See web or print catalog for P/Ns ity; samples can be amplified using either single- or double-round amplifica-
tion, and the reagent cocktails are configured to accommodate modification.
For arrays requiring biotin-labeled samples, the MessageAmp Premier and
MessageAmp III RNA Amplification Kits are available. For preparation of
fluorescently-labeled samples, we recommend the Amino Allyl MessageAmp
II Kits, which are available with and without Cy™3 and Cy5 dyes. Bacterial
RNA can be amplified using the MessageAmp II Bacteria RNA Amplification
Kit. The MessageAmp II-96 and Amino Allyl MessageAmp II-96 aRNA
Amplification Kits are offered for high-throughput applications.
FirstChoice® Total and Poly(A) High-quality total and poly(A) RNA from a variety of human, mouse and rat
RNA tissues and from human cell lines. DNA is removed with a stringent DNase
See web or print catalog for P/Ns treatment, and the purity and integrity of these RNAs are verified by Agilent
bioanalyzer evaluation, denaturing agarose gel electrophoresis, or Northern
analysis. FirstChoice Total RNA is prepared by methods that quantitatively
recover small RNAs (miRNA, siRNA, and snRNA). FirstChoice Total and
Poly(A) RNAs are ready for use in any application that requires highly puri-
fied, intact RNA. See the catalog or website (www4.appliedbiosystems.com)
for a complete listing of available FirstChoice RNAs.

6 I.E. Related Products Available from Invitrogen

 Introduction

RNA Isolation Kits Family of kits for isolation of total or poly(A) RNA. Included in the product
See web or print catalog for P/Ns line are kits using classical GITC and acidic phenol, one-step disrup-
tion/denaturation, phenol-free glass fiber filter or magnetic bead binding, and
combination kits. See the catalog or website (www4.appliedbiosystems.com).
GLOBINclear™ Whole Blood The GLOBINclear Whole Blood Globin Reduction Kits employ a novel,
Globin Reduction Kits non-enzymatic technology to remove >95% of the globin mRNA from whole
P/N AM1980, AM1981 blood total RNA samples. The resulting mRNA is a superior template for
RNA amplification and synthesis of labeled cDNA for array analysis. Kits are
available for treatment of human or mouse/rat whole blood total RNA.
ArrayControl™RNA Spikes The ArrayControl RNA Spikes are a set of eight control RNA transcripts
P/N AM1780 designed for the normalization and validation of glass microarray experi-
ments. The RNA Spikes range in size from 750 to 2000 bases, and each tran-
script has a 30-base 3' poly(A) tail. The precisely quantitated RNA Spikes are
designed to be added to your RNA sample before labeling, to serve as internal
controls for sample labeling and hybridization efficiency.
Biotin-11-UTP and Biotinylated UTPs are ideal for use as substrates in vitro transcription reac-
Biotin-16-UTP tions, and can be utilized by a variety of RNA polymerases, including T7, T3,
P/N AM8450, AM8451, AM8452, and SP6 RNA polymerases. Biotinylated RNA can be used in place of radio-
AM8453 actively labeled RNA in many applications with detection via one of a variety
of streptavidin-based methods.
RNA Fragmentation Reagents Amplified RNA is commonly fragmented prior to hybridization on oligonu-
P/N AM8740 cleotide microarrays to improve the hybridization kinetics and signal pro-
duced on oligonucleotide microarrays. Ambion® RNA Fragmentation
Reagents include a 10X Fragmentation Reagent and a Stop Solution.
Amino Allyl cDNA Labeling Kit The Amino Allyl cDNA Labeling Kit generates cDNA for secondary fluores-
P/N AM1705 cent dye labeling to be used for glass array analysis. It includes all the reagents,
except the amine-reactive labeling moiety (e.g. cyanine dyes) for 2-step label-
ing of cDNA. The reaction produces more labeled cDNA, more efficiently
than direct dye incorporation.
RETROscript® Kit First-strand cDNA synthesis kit. The RETROscript® Kit can be used to incor-
P/N AM1710 porate dye-modified nucleotides into cDNA using aRNA prepared with the
MessageAmp™ II Kit as a template.
5-(3-aminoallyl)-dUTP This 50 μM solution of amino allyl-modified dUTP can be used with the
P/N AM8439 RETROscript® Kit (P/N AM1710) to synthesize amine-reactive cDNA from
aRNA. The amine-reactive cDNA can then be postlabeled with any
amine-reactive label moiety.

I.E. Related Products Available from Invitrogen 7

 MessageAmp™ II aRNA Amplification Kit

II. aRNA Amplification Procedure

A. Important Parameters for Successful Amplification

Input RNA quantity and IVT Consider both the amount of sample RNA you have and the amount of
reaction incubation time aRNA needed for your analysis when planning MessageAmp II kit
experiments. These factors will influence how much input RNA to use,
whether one or two rounds of amplification should be done, and how
long to incubate the IVT reaction.
Accurate quantitation
For experiments where the aRNA yield from different samples will be
compared, it is essential to accurately quantify the input RNA used in
the MessageAmp II kit procedure. The NanoDrop 1000A Spectropho-
tometer is recommended for rapid, accurate quantitation of nucleic
acids; however, any reliable RNA quantitation method, such as tradi-
tional spectrophotometry or RiboGreen, can be used.
Recommended minimum and maximum amounts of input RNA
Table 1 shows the mass of total RNA that can be used in the
MessageAmp II aRNA Amplification procedure. Alternatively,
10–100 ng of poly(A) selected RNA can be used in the procedure. The
RNA volume must be ≤10 μL.

Table 1. Total RNA Input for MessageAmp II Procedure

Amplification Recommended Minimum Maximum
single round 1000 ng 100 ng 5000 ng
two rounds 100 ng 0.1 ng 100 ng

Determining input RNA amount and IVT reaction incubation time

The procedure can accommodate a wide range of input RNA amounts,
but for reproducible and comparable results, use a fixed amount of input
RNA for all experiments. Tailor both the amount of input RNA and the
amplification procedure to produce the amount of aRNA needed for
your microarray hybridizations. For instance, Affymetrix GeneChip
arrays require 10–15 μg of aRNA for each hybridization, but other com-
mercial and core facility arrays may require slightly more or less aRNA.
Figure 3 shows aRNA yields from different amounts of Control RNA
amplified with increasing IVT incubation times. aRNA yields from
additional RNA sources are tabulated in Table 3 on page 23. These data
show that when using 1000 ng or more RNA, a 4 hr IVT incubation
produces enough aRNA for several microarray hybridizations. When
amplifying samples with limited amounts of RNA however, (e.g.
~250 ng or less) incubating the IVT reaction for 14 hr will maximize
the amount of aRNA produced.

8 II.A. Important Parameters for Successful Amplification

 aRNA Amplification Procedure

Typically 100 ng of total RNA input is the lower limit for synthesizing
~10 μg of aRNA using a 4 hr IVT reaction. If your total RNA input will
be ~100 ng or less, we advise conducting a preliminary amplification
from a representative sample to determine how much aRNA you can
expect from your experimental samples. If the preliminary experiment
does not produce enough aRNA for two array hybridizations, repeat the
experiment using an IVT incubation as long as 14 hr and/or consider
using two rounds of amplification.

180 176

Incubation 164
160 Time
14 hr
8 hr
6 hr 136
140
4 hr
121
120
109

97
100
Yield (µg)

80
80 76

60

40

20 13 15
10 10
4 5 6
3
0
50 100 1000 5000
Total RNA Input (ng)

Figure 3. aRNA Yield vs. IVT Incubation Time and Total RNA
Input.
The indicated amounts of Control RNA (HeLa total RNA) were amplified for
the IVT incubation times shown. Although longer IVT incubation times pro-
duced more aRNA, the amount of aRNA needed for most microarrays was
obtained using a 4-hour incubation time with ≥1000 ng input RNA. Note that
this is empirical data obtained using the Control RNA provided with the kit;
aRNA yield from experimental samples may be considerably different.

RNA purity The quality of the RNA is the single most important factor affecting how
efficiently an RNA sample will be amplified using the MessageAmp II
aRNA Amplification Kit. RNA samples should be free of contaminating
proteins, DNA, and other cellular material as well as phenol, ethanol, and
salts associated with RNA isolation procedures. Impurities can lower the
efficiency of reverse transcription and subsequently reduce the level of
amplification. An effective measure of RNA purity is the ratio of absor-
bance readings at 260 and 280 nm. The ratio of A260 to A280 values should

II.A. Important Parameters for Successful Amplification 9

 MessageAmp™ II aRNA Amplification Kit

fall in the range of 1.7–2.1. RNA must be suspended in high quality water
or TE (10 mM Tris-HCl, 1 mM EDTA) or THE RNA Storage Solution
(P/N AM7000, AM7001).

RNA integrity The integrity of the RNA sample, or the proportion that is full-length,
is another important component of RNA quality. Reverse transcription
of partially degraded mRNAs will typically generate relatively short
cDNAs that potentially lack portions of the coding region. RNA
integrity can be evaluated by microfluidic analysis using the Agilent
2100 bioanalyzer and Caliper RNA LabChip® Kits. Primarily
full-length RNA will exhibit a ratio of 28S to 18S rRNA bands that
approaches 2:1. Using a bioanalyzer, the RIN (RNA Integrity Number)
can be calculated to further evaluate RNA integrity.
Denaturing agarose gel electrophoresis and nucleic acid staining can also
be used to separate and visualize the major rRNA species. When the
RNA resolves into discrete rRNA bands (i.e., no significant smearing
below each band), with the 28S rRNA band appearing approximately
twice as intense as the 18S rRNA band, then the mRNA in the sample
is likely to be mostly full-length. The primary drawback to gel electro-
phoresis is that it requires microgram amounts of RNA.
28S
80 80 80
Intact Total RNA Typical Total RNA Prep Lower Integrity RNA Prep
70 70 70
60 60 60
Fluorescence

Fluorescence

50
Fluorescence

50 50
40 18S 40 40
30 30 30
20 20 20
10 10 10
0 0 0
19 24 29 34 39 44 49 54 19 24 29 34 39 44 49 54 19 24 29 34 39 44 49 54
Time (seconds) Time (seconds) Time (seconds)

Figure 4. Bioanalyzer Images of Total RNA Preparations

These electropherograms (from the Agilent 2100 bioanalyzer) show RNA samples with decreasing integrity that are all of
sufficient quality to use as input for the MessageAmp II aRNA Amplification Kit. The trace labeled “Intact Total RNA”
represents the ideal for a bioanalyzer trace of total RNA. Notice how the ribosomal RNA peaks are at a ratio of about 2
(28S:18S) in this sample; this represents ultrahigh quality RNA in terms of integrity. Most RNA samples will more closely
resemble the center trace where there are nearly equal amounts of 28S and 18S rRNA. The trace on the right shows a fairly
typical human RNA prep with rRNA peaks that are lower than in the other two traces and where lower molecular weight
degradation products become apparent. RNA samples with suboptimal integrity can yield meaningful array analysis results
if the data are subjected to rigorous statistical analysis (Schoor et al. 2003).

Reaction incubation times The incubation times for most of the enzymatic reactions in the proce-
should be precise and dure were optimized in conjunction with the kit reagents to ensure the
consistent maximum yield of nucleic acid product in each step—adhere to them
closely. An exception is the IVT reaction, where a range of 4–14 hr incu-
bation time is acceptable (step II.F.3 on page 19). Refer to Figure 3 on
page 9 and Table 2 on page 20 to help determine what incubation time
to use. Although differences in IVT incubation time among samples has

10 II.A. Important Parameters for Successful Amplification

 aRNA Amplification Procedure

had very little, if any, effect on array results in our hands, we recommend
using uniform IVT incubation times if aRNA yield from different sam-
ples will be compared or if you want to have equal amplification of dif-
ferent samples—this will provide the most reproducible amplification
and array analysis.

Master mixes We strongly recommend preparing master mixes for the

MessageAmp II aRNA Amplification procedure. This approach reduces
the effects of pipetting error, saves time, and improves reproducibility.
Using master mixes is especially important when aRNA yield from dif-
ferent samples will be compared. A web-based master mix calculator is
available at the following address:
www4.appliedbiosystems/tools/ma2

Thorough mixing is very Below are specific instructions for mixing kit reagents, master mixes,
important for reproducibility and individual reactions. For maximum reproducibility and aRNA
yield, follow these instructions closely.
Mix each kit component after thawing.
Mix enzyme solutions by gently flicking the tube a few times before
adding them to reactions. Thaw frozen reagents completely at room
temperature (i.e., primers, nucleotides, and 10X buffers), then mix
thoroughly by vortexing, and keep on ice before use.
Mix master mixes by gentle vortexing.
After assembling master mixes, gently vortex to make a homogenous
mixture without inactivating the enzyme(s).
Mix individual reactions by pipetting and flicking the tube.
After adding master mixes or other reagents to individual reactions,
pipet up and down 2–3 times to rinse reagents from the pipet tip. Then
flick the tube with your finger 3–4 times to mix thoroughly, and finish
by centrifuging briefly to collect the reaction at the bottom of the tube.

Thermal cycler The MessageAmp II aRNA Amplification procedure is very sensitive to

recommended temperature; variable or inaccurate incubation temperatures can limit
aRNA synthesis. It is also very important that condensation does not
form in the reaction tubes during any of the incubations. Condensation
changes the composition of reaction mixtures, which can greatly reduce
yield.
• A thermal cycler with a temperature adjustable heated lid is rec-
ommended.
A calibrated thermal cycler, with a temperature-adjustable heated
lid, is recommended, for the greatest temperature control and stabil-
ity during MessageAmp II aRNA Amplification reaction incuba-
tions. Allow the thermal cycler to equilibrate to the required
temperature before placing the tubes in the block for incubation.

II.A. Important Parameters for Successful Amplification 11

 MessageAmp™ II aRNA Amplification Kit

Follow the recommended settings for the lid temperatures. Too high
a lid setting may inhibit the reaction; too low a setting may cause
condensation.
NOTE
Even if you use a hybridization oven If your thermal cycler does not have a temperature-adjustable lid, or
or incubator for most of the a thermal cycler is unavailable, calibrated hybridization ovens or
MessageAmp II aRNA Amplification incubators (at constant temperature) may also be used. Preheat incu-
reactions, a thermal cycler is
strongly recommended for the 16°C
bators so that the correct temperature has stabilized before reactions
second-strand synthesis reaction are placed in the incubator. To avoid any potential influence on the
incubation (step II.D.2 on page 15). reaction temperature from the tube holder, let tube holders equili-
Turn off the heated lid if it cannot be brate in the incubator for sufficient time, or use a tube holder that
adjusted to match the 16°C block doesn’t touch the sides and bottoms of the tubes—for example a
temperature.
floating tube support.
• Heat blocks or water baths are not recommended for
MessageAmp II aRNA Amplification reaction incubations.

Maintaining consistency Procedural consistency is very important for amplification experiments.

Consider implementing a detailed procedural plan that will be used by
everyone in the lab to maintain consistency. This type of plan will min-
imize variation due to subtle procedural differences that can influence
RNA amplification and may complicate gene expression studies. The
plan should include basic information such as the method of RNA iso-
lation, the amount of RNA to use in the procedure, and how long to
incubate the IVT reaction. It should also address specifics that are not
often included in protocols such as which tubes, tube racks, and incuba-
tors to use for each step in the process. Finally, develop a consistent
work flow. For example standardize stopping points in the method. The
idea is to standardize all of the variables discussed in this section of the
Protocol and carefully follow all the steps in order to maximize amplifi-
cation consistency among samples.

Tubes: use 0.5 mL If a 60-well thermal cycler with temperature-adjustable lid is available, it
RNase-free nonstick tubes is most convenient to conduct the MessageAmp II aRNA Amplification
procedure in 0.5 mL nonstick tubes (for example, P/N AM12350).
These can be thin-wall (PCR) tubes or ordinary-weight nonstick tubes.
0.5 mL tubes are large enough to accommodate the cDNA Binding
Buffer without having to transfer reactions to a larger tube. Their small
size and nonstick properties also keep the reaction components at the
bottom of the tube.
If your thermal cycler is equipped with a standard 96-well block, 0.2 mL
non-stick tubes can be used.

12 II.A. Important Parameters for Successful Amplification

 aRNA Amplification Procedure

B. Prepare the Wash Buffer

Add 24 mL 100% ethanol (ACS grade or better) to the bottle labeled
Wash Buffer. Mix well and mark the label to indicate that the ethanol
was added.

C. Reverse Transcription to Synthesize First Strand cDNA

Incubator needed
Thermal cycler programmed as follows:
Temp Time Cycles
42°C (50°C lid) 2 hr 1
4°C hold

It is important to follow the lid temperature recommendation; higher

lid temperatures may inhibit reverse transcription, while lower temper-
atures may cause condensation, resulting in changes to the reaction
composition.
For the following hazards, see the complete safety alert descriptions in
section VI.C. Safety Information starting on page 33.

WARNING
CHEMICAL HAZARD. 10X First Strand Buffer, ArrayScript.

1. Adjust RNA sample a. Place a maximum volume of 10 μL of total RNA (1000 ng

volume to 10 μL, if recommended) or poly(A) selected RNA (typically 10–100 ng) into a
necessary nonstick, sterile, RNase-free, 0.5 mL tube. RNA must be in high
quality water or TE. (See Table 1 on page 8 for minimum and
maximum RNA input amounts.)

NOTE
If your experiment will include RNA spikes (e.g., Ambion ArrayControl
RNA Spikes, P/N AM1780, or Affymetrix GeneChip Poly-A Control Kit,
Cat #900433), add them to samples at this step.

b. If necessary, add Nuclease-free Water to a final volume of 10 μL,

vortex briefly to mix, then centrifuge to collect the mixture at the
bottom of the tube.

2. Add 10 μL of Reverse a. At room temperature, prepare Reverse Transcription Master Mix in

Transcription Master a nuclease-free tube. Assemble enough to synthesize first strand
Mix and place at 42°C cDNA from all the RNA samples in the experiment, including ≤5%
overage to cover pipetting error. A master mix calculator to calculate
reagent amounts is available at:
www4.appliedbiosystems.com/tools/ma2

II.B. Prepare the Wash Buffer 13

 MessageAmp™ II aRNA Amplification Kit

At room temperature, assemble the Reverse Transcription Master

Mix in the order shown:
Reverse Transcription Master Mix (for a single 20 μL reaction)
Amount Component
1 μL Nuclease-free Water
1 μL T7 Oligo(dT) Primer
2 μL 10X First Strand Buffer
4 μL dNTP Mix
1 μL RNase Inhibitor
1 μL ArrayScript

b. Gently vortex the tube to make a homogenous mixture without

inactivating the enzyme, then centrifuge briefly (~5 sec) to collect the
Reverse Transcription Master Mix at the bottom of the tube and
place on ice.
c. Transfer 10 μL of Reverse Transcription Master Mix to each RNA
sample. Mix thoroughly by pipetting up and down 2–3 times, then
flicking the tube 3–4 times, and centrifuge briefly to collect the
reaction in the bottom of the tube.
d. Place the samples in the thermal cycler, and start the run.

3. Incubate for 2 hr at 42°C Incubate the reactions for 2 hr at 42°C, then centrifuge the tubes briefly
(~5 sec) to collect the contents at the bottom of the tubes.
Place the tubes on ice and immediately proceed to second strand cDNA
synthesis (below).

IMPORTANT
Proceed immediately to the next step.

D. Second Strand cDNA Synthesis

Incubator needed
Thermal cycler programmed as follows:
Temp Time Cycles
16°C (heat-disabled lid, or no lid) 2 hr 1
4°C hold

Disable the heated lid of the thermocycler if the lid temperature cannot
be set in the range 16°C to room temperature. If the lid is too hot, inhi-
bition of the reaction may occur.
For the following hazards, see the complete safety alert descriptions in
section VI.C. Safety Information starting on page 33.

14 II.D. Second Strand cDNA Synthesis

 aRNA Amplification Procedure

WARNING
CHEMICAL HAZARD. 10X Second Strand Buffer, DNA Poly-
merase, RNase H.

1. Add 80 μL Second a. On ice, prepare a Second Strand Master Mix in a nuclease-free tube
Strand Master Mix to in the order listed below. Assemble enough to synthesize second
each sample strand cDNA from all the samples in the experiment, including ≤5%
overage to cover pipetting error. A master mix calculator to calculate
reagent amounts is available at:
www4.appliedbiosystems.com/tools/ma2
Assemble the Second Strand Master Mix on ice in the order shown:
Second Strand Master Mix (for a single 100 μL reaction)
Amount Component
63 μL Nuclease-free Water
10 μL 10X Second Strand Buffer
4 μL dNTP Mix
2 μL DNA Polymerase
1 μL RNase H

b. Mix well by gently vortexing. Centrifuge briefly (~5 sec) to collect the
Second Strand Master Mix at the bottom of the tube and place on ice.
c. Transfer 80 μL of Second Strand Master Mix to each sample. Mix
thoroughly by pipetting up and down 2–3 times, then flicking the
tube 3–4 times, and centrifuge briefly to collect the reaction in the
bottom of the tube.
d. Place the tubes in a 16°C thermal cycler. It is important to cool the
thermal cycler block to 16°C before adding the reaction tubes because
subjecting the reactions to temperatures >16°C will compromise
aRNA yield.

2. Incubate for 2 hr at 16°C Incubate 2 hr in a 16°C thermal cycler. If the lid temperature cannot be
adjusted to match the 16°C block temperature, cover the reactions with
the heated lid turned off, or if the lid cannot be turned off—do not
cover the tubes with it. (Do not use a water bath or a heat block in a 4°C
refrigerator for this incubation because the temperature will fluctuate
too much.)

II.D. Second Strand cDNA Synthesis 15

 MessageAmp™ II aRNA Amplification Kit

3. Place reactions on ice After the 2 hr incubation at 16°C, place the reactions on ice and pro-
briefly or freeze ceed to section E. cDNA Purification (below), or immediately freeze
immediately reactions at –20°C. Do not leave the reactions on ice for more than 1 hr.

STOPPING POINT
This is a potential overnight stopping point (at –20°C), but it is better to com-
plete the cDNA purification (next section) before stopping.

E. cDNA Purification
IMPORTANT
All centrifugations in this purification procedure should be done at 10,000 x g
(typically ~10,000 rpm) at room temperature.
cDNA Filter Cartridges should not be subjected to RCFs over 16,000 x g
because the force could cause mechanical damage and/or may deposit glass
filter fiber in the eluate.

For the following hazard, see the complete safety alert descriptions in
section VI.C. Safety Information starting on page 33.

WARNING
CHEMICAL HAZARD. cDNA Binding Buffer.

1. Preheat Nuclease-free Before beginning the cDNA purification, preheat at least 20 μL per
Water to 55°C sample of Nuclease-free Water to 55°C.

IMPORTANT
Preheat the Nuclease-free Water to a maximum of 55°C; temperatures above
58°C can partially denature the cDNA, compromising final aRNA yield.

2. Add 250 μL cDNA Binding

Buffer to each sample IMPORTANT
Check the cDNA Binding Buffer for precipitation before using it. If a precipi-
tate is visible, redissolve it by warming the solution to 37°C for up to 10 min
and vortexing vigorously. Cool to room temperature before use.

Add 250 μL of cDNA Binding Buffer to each sample, and mix thor-
oughly by pipetting up and down 2–3 times, then flicking the tube
3–4 times. Follow up with a quick spin to collect the reaction in the bot-
tom of the tube. Proceed quickly to the next step.

3. Pass the mixture through Check that the cDNA Filter Cartridge is firmly seated in its wash tube
a cDNA Filter Cartridge (supplied).
a. Pipet the cDNA sample/cDNA Binding Buffer (from step 2) onto
the center of the cDNA Filter Cartridge.
b. Centrifuge for ~1 min at 10,000 x g, or until the mixture is through
the filter.

16 II.E. cDNA Purification

 aRNA Amplification Procedure

c. Discard the flow-through and replace the cDNA Filter Cartridge in

the wash tube.

IMPORTANT
Make sure that the ethanol has been added to the bottle of Wash Buffer
before using it in this step.

4. Wash with 500 μL Wash a. Apply 500 μL Wash Buffer to each cDNA Filter Cartridge.
Buffer
b. Centrifuge for ~1 min at 10,000 x g, or until all the Wash Buffer is
through the filter.
c. Discard the flow-through and spin the cDNA Filter Cartridge for an
additional minute to remove trace amounts of Wash Buffer.
d. Transfer cDNA Filter Cartridge to a cDNA Elution Tube.

5. Elute cDNA with 18 μL It is important to use Nuclease-free Water that is at 50–55°C for the
55°C Nuclease-free Water cDNA elution. Colder water will be less efficient at eluting the cDNA,
and hotter water (≥58° C) may result in reduced aRNA yield.
a. Apply 18 μL of preheated Nuclease-free Water (55°C) to the center
of the filter in the cDNA Filter Cartridge.
b. Leave at room temperature for 2 min and then centrifuge for 1 min at
10,000 x g, or until all the Nuclease-free Water is through the filter.
The double-stranded cDNA will now be in the eluate (~16 μL).

STOPPING POINT
The purified cDNA can be stored overnight at –20°C at this point if
desired. Transfer the cDNA to a lidded, non-stick, nuclease-free tube for
storage.

F. In Vitro Transcription to Synthesize aRNA

Incubator needed
Thermal cycler programmed as follows:
Temp Time Cycles
37°C (default lid; 100–105°C) 4–14 hr; see step 3 1
4°C hold

It is important to use a thermal cycler with a heated lid (100–105°C), to

maintain uniform temperature, and because it is extremely important
that condensation does not form inside the tubes; this would change the
reagent concentrations and reduce yield.

II.F. In Vitro Transcription to Synthesize aRNA 17

 MessageAmp™ II aRNA Amplification Kit

The IVT reaction can be set up to synthesize unmodified aRNA, or bio-

tin-labeled UTP (or other modified nucleotides) can be incorporated
into the aRNA during the IVT. Samples that will undergo two rounds
of amplification cannot be labeled with biotin at this step because it
would interfere with the second round of amplification.
For the highest aRNA yield, conduct the IVT in a 40 μL final reaction
volume. We provide instructions for a 20 μL biotin-labeled reaction for
users who want to reduce the reaction cost by using only half the quan-
tity of biotin-labeled nucleotide.
For the following hazards, see the complete safety alert descriptions in
section VI.C. Safety Information starting on page 33.

WARNING
CHEMICAL HAZARD. 10X T7 Reaction Buffer, T7 Enzyme Mix.
1.

1a. For 20 μL IVT reactions, If you will be conducting a 20 μL IVT reaction, concentrate the eluted
concentrate the cDNA cDNA from step II.E.5 on page 17 in a vacuum centrifuge concentrator
until the volume is reduced to 8 μL. This should take only a few min-
utes. Avoid drying the mixture to completion.

1b. For 40 μL IVT reactions, If you will be conducting a 40 μL IVT reaction, using unmodified or
proceed directly to biotin-labeled UTP, transfer the eluted cDNA from step II.E.5 on
step 2 page 17 to a PCR tube and proceed directly to step 2 below.

2. Add IVT Master Mix to a. At room temperature, prepare an IVT Master Mix by adding the
each sample, and mix following reagents to a nuclease-free microcentrifuge tube in the
order listed below. Assemble enough for all the samples in the
experiment, including ≤5% overage to cover pipetting error. We
provide a master mix calculator on our website to calculate reagent
amounts:
www4.appliedbiosystems.com/tools/ma2

IMPORTANT
If two rounds of amplification will be done, this first round transcription
should be unmodified, containing only unmodified UTP.

18 II.F. In Vitro Transcription to Synthesize aRNA

 aRNA Amplification Procedure

Assemble the IVT Master Mix at room temperature in the order

shown:

Biotin labeled Unmodified

40 μL rxn 20 μL rxn 40 μL rxn Component
–– (8 μL) –– concentrated cDNA from step 1a on page 18
(16 μL) –– (16 μL) double-stranded cDNA (from step II.E.5 on page 17)
IVT Master Mix for a single reaction
4 μL 2 μL 4 μL T7 ATP
4 μL 2 μL 4 μL T7 CTP
4 μL 2 μL 4 μL T7 GTP
2.6 μL 1.3 μL 4 μL T7 UTP
1.4 μL 0.7 μL –– Biotin-11-UTP*, 75 mM
4 μL 2 μL 4 μL T7 10X Reaction Buffer
4 μL 2 μL 4 μL T7 Enzyme Mix
* Biotin-16-UTP can be used instead of Biotin-11-UTP, if needed.

b. Mix well by gently vortexing. Centrifuge briefly (~5 sec) to collect the
IVT Master Mix at the bottom of the tube and place on ice.
c. Transfer IVT Master Mix to each sample following the volume
guidelines below. Mix thoroughly by pipetting up and down 2–3
times, then flicking the tube 3–4 times, and centrifuge briefly to
collect the reaction in the bottom of the tube.

IMPORTANT
If the cDNA was vacuum dried, resuspend the template by washing the
sides of the tube with the IVT Master Mix as you add it to the tube. It is
important to make sure that all of the material is resuspended in the IVT
reaction mix before the mixture is transferred to a PCR tube for IVT.

Biotin labeled Unmodified

40 μL rxn 20 μL rxn 40 μL rxn
24 μL 12 μL 24 μL volume IVT Master Mix

d. Once assembled, place the tubes in the thermal cycler and start the run.

3. Incubate 4–14 hr at 37°C The minimum recommended incubation time is 4 hr; the maximum is
14 hr. (The reactions can be held post-IVT at 4°C for up to 48 hr, for
convenience.)
Use the following table as a guide to determine how long to continue
your IVT reaction. There are more data and a detailed discussion of the
length of the IVT incubation in section II.A Input RNA quantity and
IVT reaction incubation time starting on page 8.

II.F. In Vitro Transcription to Synthesize aRNA 19

 MessageAmp™ II aRNA Amplification Kit

Table 2. Recommended IVT Incubation TImes

aRNA Needed Input Total RNA IVT Incubation
10–100 μg 1–5 μg 4 hr
1–10 μg 0.1–1 μg 8 hr
0.1–1 μg ≤100 ng 14 hr

4. Add Nuclease-free Water Stop the reaction by adding Nuclease-free Water to each aRNA sample
to bring each sample to to bring the final volume to 100 μL. Mix thoroughly by gentle vortexing.
100 μL
Proceed to the aRNA purification step (below) or store at –20°C.

STOPPING POINT
The aRNA can be stored overnight at –20°C at this point if desired.

G. aRNA Purification
Incubator needed: heat block set at 55°C.
This purification removes enzymes, salts, and unincorporated nucle-
otides from the aRNA. At the end of the purification the aRNA is eluted
from the filter with Nuclease-free Water.

IMPORTANT
All centrifugations in this purification procedure should be done at 10,000 x g
(typically ~10,000 rpm) at room temperature.
aRNA Filter Cartridges should not be subjected to RCFs over 16,000 x g
because the force could cause mechanical damage and/or may deposit glass
filter fiber in the eluate.

1. Preheat Nuclease-free • Preheat a minimum of 200 μL per sample of Nuclease-free Water to

Water and assemble Filter 55°C.
Cartridges and Tubes • For each sample, place an aRNA Filter Cartridge into an aRNA Col-
lection Tube and set aside for use in step 4.
For the following hazards, see the complete safety alert descriptions in
section VI.C. Safety Information starting on page 33.

WARNING
CHEMICAL HAZARD. aRNA Binding Buffer.

2. Add 350 μL aRNA Binding a. Check to make sure that each IVT reaction was brought to 100 μL
Buffer to each sample with Nuclease-free Water.
b. Add 350 μL of aRNA Binding Buffer to each aRNA sample. Proceed
to the next step immediately.

20 II.G. aRNA Purification

 aRNA Amplification Procedure

3. Add 250 μL 100% ethanol Add 250 μL of ACS grade 100% ethanol to each aRNA sample, and
and pipet 3 times to mix mix by pipetting the mixture up and down 3 times. Do NOT vortex to
mix and do NOT centrifuge.
IMPORTANT
It is crucial to follow these mixing Proceed immediately to the next step as soon as you have mixed the eth-
instructions exactly, and to proceed anol into each sample. Any delay in proceeding could result in loss of
quickly to the next step. aRNA because once the ethanol is added, the aRNA will be in a semi-
precipitated state.

4. Pass samples through an a. Pipet each sample mixture from step 3 onto the center of the filter in
aRNA Filter Cartridge the aRNA Filter Cartridge/Collection Tube assembly.
b. Centrifuge for ~1 min at 10,000 x g. Continue until the mixture has
passed through the filter.
c. Discard the flow-through and replace the aRNA Filter Cartridge back
into the aRNA Collection Tube.

5. Wash with 650 μL Wash a. Apply 650 μL Wash Buffer to each aRNA Filter Cartridge.
Buffer
b. Centrifuge for ~1 min at 10,000 x g, or until all the Wash Buffer is
through the filter.
c. Discard the flow-through and spin the aRNA Filter Cartridge for an
additional ~1 min to remove trace amounts of Wash Buffer.
d. Transfer Filter Cartridge(s) to a fresh aRNA Collection Tube.

6. Elute aRNA with 200 μL a. To the center of the filter, add 200 μL Nuclease-free Water
55°C Nuclease-free Water (preheated to 55°C).
b. Incubate the samples in the 55°C heat block for 10 min
(recommended).
Alternatively, incubate at room temperature for 2 min. This results
in ~80% recovery of the aRNA.
c. Centrifuge for ~1.5 min at 10,000 x g, or until the Nuclease-free
Water is through the filter.
d. The aRNA will now be in the aRNA Collection Tube in ~200 μL of
Nuclease-free Water.

7. Store aRNA at –80°C Store aRNA at –80°C for up to 1 year, and minimize repeated
freeze-thawing. To prevent multiple freeze-thaw events, split samples
into 5–20 μg aliquots for microarray labeling and hybridizations.

8. (Optional) Concentrate If necessary, concentrate the aRNA by vacuum centrifugation or by pre-

the purified aRNA cipitation with ammonium acetate (NH4OAc)/ethanol.

II.G. aRNA Purification 21

 MessageAmp™ II aRNA Amplification Kit

(Optional) Concentrate by vacuum centrifugation

If the heater on the vacuum centrifuge has different settings, use
medium or low. Check the progress of drying every 5–10 min, and
remove the sample from the concentrator when it reaches the desired
volume.
(Optional) Precipitate with 5 M NH4OAc and ethanol

a. Add 0.1 volume of 5 M NH4OAc to the purified aRNA (20 μL if the

aRNA was eluted in 200 μL Nuclease-free water).
b. Add 2.5 volumes of 100% ethanol (550 μL if the aRNA was eluted in
200 μL). Mix well and incubate at –20°C for 30 min.
c. Microcentrifuge at top speed for 15 min at 4°C or room temperature.
Carefully remove and discard the supernatant.
d. Wash the pellet with 500 μL 70% cold ethanol, centrifuge again, and
remove the 70% ethanol.
e. To remove the last traces of ethanol, quickly respin the tube, and
aspirate any residual fluid with a fine-tipped pipette or syringe needle.
f. Air dry the pellet.
g. Resuspend the aRNA pellet using the desired solution and volume.

22 II.G. aRNA Purification

 Assessing aRNA Yield and Quality

III. Assessing aRNA Yield and Quality

A. aRNA Quantitation and Expected Yield

1. Assessing aRNA yield by The concentration of an aRNA solution can be determined by measuring
UV absorbance its absorbance at 260 nm using a spectrophotometer.
• Use a NanoDrop spectrophotometer and measure 1.5 μL of the
RNA sample directly.
• With a traditional spectrophotometer, dilute an aliquot of the RNA
1:50 to 1:100 in TE (10 mM Tris-HCl pH 8, 1 mM EDTA), and
read the absorbance. (Be sure to zero the spectrophotometer with the
TE used for sample dilution.) The buffer used for dilution need not
be RNase-free, since slight degradation of the RNA will not signifi-
cantly affect its absorbance.
Find the concentration in μg/mL by multiplying the A260 by the dilu-
tion factor and the extinction coefficient. (1 A260 = 40 μg RNA/mL):
A260 X dilution factor X 40 = μg RNA/mL

2. Assessing aRNA yield If a fluorometer or a fluorescence microplate reader is available, Molec-

with the RiboGreen® ular Probes’ RiboGreen fluorescence-based assay for RNA quantitation
assay is a convenient and sensitive way to measure RNA concentration. Fol-
low the manufacturer’s instructions for using RiboGreen.

3. Expected yield The aRNA yield will depend on the amount and quality of poly(A)
RNA in the input total RNA. Since the proportion of poly(A) RNA in
total RNA is affected by influences such as health of the organism and
the organ from which it is isolated, aRNA yield from equal amounts of
total RNA may vary considerably. The following table shows empirical
aRNA yield data obtained using this kit.
Table 3. aRNA Yields from Different Amounts of Selected RNAs
Amplified Using a 4 hr IVT Incubation.
Input total RNA used in MessageAmp II
RNA source 50 ng 100 ng 500 ng 1 μg 3 μg
Human brain 4.2 12.1 47.1 127.0 204.6
synthesized (μg)
Amount of aRNA

Human heart 2.3 6.7 23.3 57.1 126.8

Human kidney 2.0 4.0 21.3 39.0 93.9
HeLa S3 cells 5.3 11.5 59.1 87.3 89.7
Rat thymus 2.4 4.0 23.1 46.5 100.5
Universal Human — — 47.3 75 105.9
Reference RNA*

* Stratagene

III.A. aRNA Quantitation and Expected Yield 23

 MessageAmp™ II aRNA Amplification Kit

B. Analysis of aRNA Size

The size distribution of aRNA can be evaluated using an Agilent 2100
bioanalyzer with Caliper's LabChip technology, or by conventional
denaturing agarose gel analysis. The bioanalyzer can provide a fast and
accurate size distribution profile of aRNA samples, but aRNA yield
should be determined by UV absorbance or RiboGreen analysis. To
analyze aRNA size using a bioanalyzer, follow the manufacturer’s
instructions for running the assay using purified aRNA (from
step II.G.6 on page 21). Instructions for denaturing agarose gel electro-
phoresis are available at:
www4.appliedbiosystems.com/techlib/append/supp/rna_gel.html

Expected aRNA size Agilent bioanalyzer analysis

The expected aRNA profile is a distribution of sizes 250–5500 nt with
most of the aRNA 1000–1500 nt (Figure 5). To compare bioanalyzer
profiles of different aRNA samples, be sure to load equal mass amounts
to get an accurate comparison.
Denaturing agarose gel analysis
Amplified aRNA should appear as a smear from 250 to 5000 nt. The
average size of biotin labeled aRNA should be approximately 1400 nt;
the average size of unmodified aRNA should be ~1150 nt.

3.5
MessageAmp II aRNA
3.0 RNA 6000 Ladder
(0.2, 0.5, 1, 2, 4, and 6 kb RNA markers)

2.5

2.0
Fluorescence

0.2

1.5
0.5

1.0 1 2
4
0.5
6

0.0

14 19 24 29 34 39 44 49 54 59 64 69 74 79 84
Time (seconds)

Figure 5. Bioanalyzer Analysis of a Biotin-Labeled

MessageAmp™ II aRNA Amplification Kit Reaction.
This electropherogram displays the aRNA size distribution from 1 round of
amplification of 1 μg of the Control RNA using biotin labeled NTPs in a
40 μL IVT reaction that was incubated for 14 hr. Using the Agilent bioana-
lyzer mRNA smear assay, 50% of the aRNA is calculated to be larger than
1470 nt. (The vertical grey lines mark 65 and 1470 bases. The area outside
these lines represents 50% of the area under the curve produced by the product
of the positive control reaction.)

24 III.B. Analysis of aRNA Size

 (Optional) Second Round Amplification

IV. (Optional) Second Round Amplification

If one cycle of amplification does not yield the amount of aRNA neces-
sary for your experiments, a second round of amplification can be con-
ducted to generate additional aRNA (see Figure 2 on page 3 for an
overview of second round amplification). In order to conduct two
rounds of amplification, the first round of amplification must contain
only unmodified CTP and UTP; modified aRNA cannot undergo a
second round of amplification.
The procedure is similar to the first round of amplification, and the
reaction products are equivalent, but different primers are used for first
and second strand synthesis, and the reaction setup is slightly different.
Second round amplification products are typically shorter than first
round amplification products, but we have not seen that this has adverse
effects on array hybridization results if all samples are prepared using
two rounds of amplification.

A. Synthesis of First Strand cDNA (Second Round)

Incubator needed
Thermal cycler programmed as follows:
Temp Time Cycles
37°C (default lid; 100–105°C) 30 min 1
4°C hold

It is important to use a thermal cycler with a heated lid (100–105°C), to

maintain uniform temperature, and because it is extremely important
that condensation does not form inside the tubes; this would change the
reagent concentrations and reduce yield.

1. Mix ≤2 μg aRNA with 2 μL a. Place up to 2 μg of purified aRNA from the first round of
Second Round Primers, amplification into a sterile RNase-free microcentrifuge tube.
and adjust the volume to With very small RNA samples, we have dried the entire first round
12 μL amplification reaction, and used it as starting material for the second
round amplification.

IMPORTANT
The volume of the aRNA must be ≤10 μL. If necessary, concentrate the
aRNA in a vacuum centrifuge. Do not dry the aRNA completely, as this
could impede reverse transcription.

b. Add 2 μL of Second Round Primers.

c. Add Nuclease-free Water to bring the volume to 12 μL, vortex briefly
to mix, and centrifuge briefly to collect the reaction in the bottom of
the tube.

IV.A. Synthesis of First Strand cDNA (Second Round) 25

 MessageAmp™ II aRNA Amplification Kit

2. Incubate 10 min at 70°C a. Program a thermal cycler for the annealing step:
Temp Time Cycles
70°C (default lid; 100–105°C) 10 min 1
4°C hold

b. Place the samples in the equilibrated thermal cycler, start the run, and
incubate for 10 minutes at 70°C.
It is important to follow the lid temperature recommendation;
higher lid temperatures may inhibit reverse transcription, while
lower temperatures may cause condensation, resulting in changes to
the reaction composition.
c. Remove the RNA samples from the 70°C incubation and centrifuge
briefly (~5 sec) to collect the reaction at the bottom of the tube. Place
the reaction on ice briefly before starting step 3.

3. Add 8 μL of Reverse a. While the samples are incubating at 70°C, prepare Reverse
Transcription Master Mix Transcription Master Mix in a nuclease-free tube at room
and place at 42°C temperature. Assemble enough master mix for all of the samples in
the experiment, including ≤5% overage to cover pipetting error. A
master mix calculator to calculate reagent amounts is available at:
www4.appliedbiosystems/tools/ma2
Assemble the Reverse Transcription Master Mix in the order shown:
Reverse Transcription Master Mix (for a single 20 μL reaction)
Amount Component
2 μL 10X First Strand Buffer
4 μL dNTP Mix
1 μL RNase Inhibitor
1 μL ArrayScript

b. Mix well by gently vortexing. Centrifuge briefly (~5 sec) to collect the
Reverse Transcription Master Mix at the bottom of the tube and
place on ice.
c. Transfer 8 μL of Reverse Transcription Master Mix to each sample.
Mix thoroughly by pipetting up and down 2–3 times, then flicking
the tube 3–4 times, and centrifuge briefly to collect the reaction in
the bottom of the tube.
d. Program the thermal cycler for the reverse transcription reaction:
Temp Time Cycles
42°C (50°C lid) 2 hr 1
4°C hold

e. Place the tubes in the thermal cycler which has equilibrated to 42°C
and start the run.

26 IV.A. Synthesis of First Strand cDNA (Second Round)

 (Optional) Second Round Amplification

4. Incubate 2 hr at 42°C Incubate reactions for 2 hr at 42°C, then centrifuge briefly (~5 sec) to
collect the reaction at the bottom of the tube.

5. Add 1 μL RNase H and RNase H specifically degrades the aRNA leaving only the cDNA as
incubate 30 min at 37°C template for second strand synthesis. This helps assure that the second
strand synthesis reaction will be primed exclusively by the T7 Oligo(dT)
Primer.
a. Add 1 μL RNase H to each reaction. Mix thoroughly by pipetting up
and down 2–3 times, then flicking the tube 3–4 times, and centrifuge
briefly to collect the reaction in the bottom of the tube.
b. Incubate for 30 min at 37°C in a thermal cycler. After the incubation,
proceed directly to Second Strand Synthesis (below).

B. Synthesis of Second Strand cDNA (Second Round)

Incubator needed:
Thermal cycler with a temperature-adjustable lid

1. Add 5 μL T7 Oligo(dT) a. Add 5 μL T7 Oligo(dT) Primer to cDNA sample.

Primer to each sample
b. Mix well by gently vortexing, then centrifuge briefly (~5 sec) to
collect the sample at the bottom of the tube.

2. Incubate for 10 min at a. Program a thermal cycler for the annealing step:
70°C, then place on ice Temp Time Cycles
70°C (default lid; 100–105°C) 10 min 1
4°C hold

b. Place the samples in the equilibrated thermal cycler, start the run, and
incubate 10 min at 70°C in a thermal cycler.
c. Place the reaction on ice briefly before adding the remaining second
strand cDNA synthesis reagents.

3. Add 74 μL Second Strand a. On ice, Assemble Second Strand Master Mix for all the samples in the
Master Mix to each experiment, including ≤5% overage to cover pipetting error. A master
sample mix calculator to calculate reagent amounts is available at:
www4.appliedbiosystems/tools/ma2
Assemble the Second Strand Master Mix on ice in the order shown:
Second Strand Master Mix (for a single 100 μL reaction)
Amount Component
58 μL Nuclease-Free Water
10 μL 10X Second Strand Buffer
4 μL dNTP Mix
2 μL DNA Polymerase

IV.B. Synthesis of Second Strand cDNA (Second Round) 27

 MessageAmp™ II aRNA Amplification Kit

b. Mix well by gently vortexing. Centrifuge briefly (~5 sec) to collect the
Second Strand Master Mix at the bottom of the tube and place on ice.
c. Transfer 74 μL of Second Strand Master Mix to each sample. Mix
thoroughly by pipetting up and down 2–3 times, then flicking the
tube 3–4 times, and centrifuge briefly to collect the reaction in the
bottom of the tube.
d. Program a thermal cycler for the reverse transcription reaction:
Temp Time Cycles
16°C (heat-disabled lid, or no lid) 2 hr 1
4°C hold

Disable the heated lid of the thermocycler if the lid temperature can-
not be set in the range 16°C to room temperature. If the lid is too
hot, inhibition of the reaction may occur.
e. Place the tubes in the pre-cooled 16°C thermal cycler. It is important
to cool the thermal cycler block to 16°C before placing the reaction
tubes; subjecting the reactions to temperatures >16°C could
compromise aRNA yield.

4. Incubate 2 hr at 16°C Incubate 2 hr in a 16°C thermal cycler. If the lid temperature cannot be
adjusted to match the 16°C block temperature, cover the reactions with
the heated lid turned off, or if the lid cannot be turned off—do not
cover the reactions. (Do not use a water bath or a heat block in a 4°C
refrigerator for this incubation because the temperature will fluctuate
too much.)

STOPPING POINT
This is a potential overnight stopping point, but it is better to complete the
cDNA purification (section II.E on page 16) before stopping.

5. Continue with the After the 2 hr incubation at 16°C, place the reactions on ice and pro-
procedure at section II.E ceed to section II.E. cDNA Purification on page 16, or immediately
starting on page 16 freeze reactions at –20°C. Do not leave the reactions on ice for long
periods of time.
Complete the rest of the second round amplification; start at
section II.E. cDNA Purification on page 16, and continue through the
remainder of section II.

28 IV.B. Synthesis of Second Strand cDNA (Second Round)

 Troubleshooting

V. Troubleshooting

A. Positive Control Reaction

Control RNA amplification To establish if the kit is working properly, Control RNA consisting of
instructions 1 mg/mL HeLa cell total RNA is provided.
1. Use 1 μL of the Control RNA in a single-round MessageAmp II kit
reaction; follow the procedure starting at step II.C.1 on page 13.
2. At step II.F.3 on page 19, use a 14 hr incubation for the IVT reac-
tion.
3. Continue with the procedure for making unmodified aRNA through
section II.G.

Analysis of the positive • After completing the aRNA purification, measure the A260 of the
control amplification reaction product as described in section III.A.1 on page 23.
reaction The positive control reaction should produce ≥50 μg of aRNA.
Be aware that often the positive control reaction cannot be compared
to experimental reactions, because many experimental amplification
experiments will use less than the 1 μg of input RNA used in the pos-
itive control reaction, and the aRNA yield will be proportionately
lower. Also the Control RNA is of exceptional quality and purity,
ensuring that it will amplify with extremely high efficiency.
• Also run a 2 μg aliquot of the reaction products on a denaturing aga-
rose gel or analyze 100–200 ng on a bioanalyzer; the average size of
the aRNA should be ≥1 kb.

B. Factors that Affect Both the Positive Control and Experimental Samples
If the positive control reaction yield or amplification product size does
not meet expectations, consider the following possible causes and trou-
bleshooting suggestions. These suggestions also apply to problems with
amplification of experimental RNA.

Incubation temperature(s) The incubation temperatures are critical for effective RNA amplification.
were incorrect • Check the temperatures of all incubators used in the procedure with
a calibrated thermometer.
• If a thermal cycler is used for incubation, check the accuracy of the
adjustable temperature lid. If the lid temperature cannot be adjusted
to match the desired reaction temperature, use the lid with the heat
turned off, or do not use the lid to cover the reaction vessel(s).

V.A. Positive Control Reaction 29

 MessageAmp™ II aRNA Amplification Kit

Condensation formed in the Condensation occurs when the cap of the reaction vessel is cooler (e.g.,
tube during the reaction room temperature) than the bottom of the tube. As little as 1–2 μL of
incubation(s) condensate in an IVT reaction tube throws off the concentrations of the
nucleotides and magnesium, which are crucial for good yield.
If you see condensation, spin the tube briefly and mix the reaction gen-
tly. Move the tube(s) to an incubator where condensation does not
occur or is minimized.

Nuclease-contaminated Using pipettes, tubes, or equipment that are contaminated with nucle-
tubes, tips, or equipment ases can cleave the RNA or DNA being generated at each step in the
procedure. This will reduce the size of the aRNA products and decrease
aRNA yield. Both RNases and DNases can be removed from surfaces
using Ambion RNaseZap® RNase Decontamination Solution
(P/N AM9780, AM9786).

Absorbance readings were Confirm that your spectrophotometer is accurate by measuring the
inaccurate absorbance of an RNA or DNA sample of known concentration. Alter-
natively, assess the aRNA concentration by fractionating on an agarose
gel adjacent to an RNA sample whose concentration is known. Com-
paring the ethidium bromide staining of the aRNA and control samples
can approximate the concentration of the aRNA.

C. Troubleshooting Low Yield and Small Average aRNA Size

Consider the following troubleshooting suggestions if the positive con-
trol reaction produced the expected results, but amplification of your
experimental samples results in less or smaller (average <500 nt) aRNA
than expected.

Impure RNA samples RNA samples with significant amounts of contaminating DNA, protein,
phenol, ethanol, or salts are reverse transcribed poorly and subsequently
generate less aRNA than pure RNA samples. Phenol extract and ethanol
precipitate your RNA, or use the Ambion MEGAclear™ Kit
(P/N AM1908) to further purify your RNA before reverse transcription.

Lower than expected input Take another A260 reading of your RNA sample or try using more RNA
RNA concentration in the aRNA amplification procedure.

RNA integrity is RNA that is partially degraded generates cDNA that is relatively short.
compromised This will reduce the average size of the aRNA population and subse-
quently reduce the yield of aRNA. You can assess the integrity of an
RNA sample by determining the size of the 18S and 28S rRNA bands
and the relative abundance of 28S to 18S rRNA (See RNA integrity on
page 10 for more information).

30 V.C. Troubleshooting Low Yield and Small Average aRNA Size

 Troubleshooting

The mRNA content of your Different RNA samples contain different amounts of mRNA. In
total RNA sample is lower healthy cells, mRNA constitutes 1–3% of total cellular RNA. The actual
than expected amount of mRNA depends on the cell type and the physiological state
of the sample. When calculating the amount of amplification, the start-
ing mass of mRNA in a total RNA prep should always be considered
within a range of 10–30 ng per μg of total RNA (assuming good RNA
quality). Most total RNA samples can be amplified up to 1000 fold pro-
ducing 10–30 μg of aRNA from 1 μg of total RNA.

D. aRNA is Not Efficiently Reverse Transcribed

The cDNA procedure relies The aRNA has a poly(U) tract near the 5' end but lacks a poly(A) tract
on oligo(dT) priming at its 3' end. Thus any reverse transcription procedures that rely on
oligo(dT) primers will not effectively convert aRNA to cDNA. Try
using gene specific or random primers.

The filter in the aRNA Filter If the aRNA contains ethanol carried over from the Wash Buffer, it can
Cartridge was not inhibit reverse transcription. Make sure that the filter is completely dry
completely dried after the at step II.G.5.c on page 21 just before eluting the aRNA.
wash steps
To remove ethanol from an aRNA sample, ethanol precipitate it follow-
ing the instructions in step II.G.8 on page 21, Be sure to include the
double spin described in step 8.e to remove the last traces of ethanol
before air drying the aRNA pellet.

Absorbance readings are Confirm that your spectrophotometer is accurate by measuring the
inaccurate absorbance of an RNA or DNA sample of known concentration. Alter-
natively, assess the quantity of aRNA by a different method such as frac-
tionating on an agarose gel adjacent to an RNA sample whose
concentration is known and comparing the ethidium bromide staining
or using a sensitive RNA dye such as RiboGreen.

V.D. aRNA is Not Efficiently Reverse Transcribed 31

 MessageAmp™ II aRNA Amplification Kit

VI. Appendix

A. References
Feldman AJ, Costouros NG, Wang E, Qian M, Marincola FM, Alexander HR, and Libutti SK (2002) Advan-
tages of mRNA amplification for microarray analysis. Biotechniques 33(4):906–914.
Kacharmina JE, Crino PB, Eberwine J (1999) Preparation of cDNA from single cells and subcellular regions.
Methods Enzymol, 303:3–18.
Li Y, Li T, Liu S, Qiu M, Han Z, Jiang Z, Li R, Ying K, Xie Y, Mao Y (2004) Systematic comparison of the
fidelity of aRNA, mRNA and T-RNA on gene expression profiling using cDNA microarray. J Biotechnology
107(1):19–28.
Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR,
Erlander MG (1999) Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med
5(1):117–122.
Pabon C, Modrusan Z, Ruvolo MV, Coleman IM, Daniel S, Yue H, Arnold LJ Jr. (2001) Optimized T7
amplification system for microarray analysis. Biotechniques 31(4):874–879.
Polacek DC, Passerini AG, Shi C, Francesco NM, Manduchi E, Grant GR, Powell S, Bischof H, Winkler H,
Stoeckert CJ Jr, Davies PF (2003) Fidelity of enhanced sensitivity of differential transcription profiles following
linear amplification of nanogram amounts of endothelial mRNA. Physiol Genomics 13:147–156.
Schoor O, Weinschenk T, Hennenlotter J, Corvin S, Stenzl A, Rammensee H-G, and Stevanovic S (2003)
Moderate degradation does not preclude microarray analysis of small amounts of RNA. Biotechniques
35:1192–1201.
Van Gelder RN, von Xastrow ME, Yool A, Dement DC, Barchas JD, Eberwine JH (1990) Amplified RNA
synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA, 87:1663–1667.
Yue H, Eastman PS, Wang BB, Minor J, Doctolero MH, Nuttall RL, Stack R, Becker JW, Montgomery JR,
Vainer M, Johnston R (2001) An evaluation of the performance of cDNA microarrays for detecting changes in
global mRNA expression. Nucleic Acids Res 29(8):E41–1.

B. Quality Control

Functional testing The Control RNA is used in a MessageAmp II kit reaction following the
instructions in section V.A on page 29. The aRNA yield is assessed by
measuring the A260 on the NanoDrop ND1000A spectrophotometer.
The median size of the aRNA is assessed using the mRNA smear assay
on the Agilent 2100 bioanalyzer.

Nuclease testing Relevant kit components are tested in the following nuclease assays:
RNase activity
Meets or exceeds specification when a sample is incubated with labeled
RNA and analyzed by PAGE.

32 VI.A. References
 Appendix

Nonspecific endonuclease activity

Meets or exceeds specification when a sample is incubated with super-
coiled plasmid DNA and analyzed by agarose gel electrophoresis.
Exonuclease activity
Meets or exceeds specification when a sample is incubated with labeled
double-stranded DNA, followed by PAGE analysis.

Protease testing Meets or exceeds specification when a sample is incubated with protease
substrate and analyzed by fluorescence.

C. Safety Information

C.I. General chemical safety

Chemical safety guidelines To minimize the hazards of chemicals:

• Read and understand the Material Safety Data Sheets (MSDS) pro-
vided by the chemical manufacturer before you store, handle, or
work with any chemicals or hazardous materials.
• Minimize contact with chemicals. Wear appropriate personal protec-
tive equipment when handling chemicals (for example, safety gog-
gles, gloves, or protective clothing). For additional safety guidelines,
consult the MSDS.
• Minimize the inhalation of chemicals. Do not leave chemical con-
tainers open. Use only with adequate ventilation (for example, fume
hood). For additional safety guidelines, consult the MSDS.
• Check regularly for chemical leaks or spills. If a leak or spill occurs,
follow the manufacturer’s cleanup procedures as recommended on
the MSDS.
• Comply with all local, state/provincial, or national laws and regula-
tions related to chemical storage, handling, and disposal.

About MSDSs Chemical manufacturers supply current Material Safety Data Sheets
(MSDSs) with shipments of hazardous chemicals to new customers.
They also provide MSDSs with the first shipment of a hazardous chem-
ical to a customer after an MSDS has been updated. MSDSs provide the
safety information you need to store, handle, transport, and dispose of
the chemicals safely.
Each time you receive a new MSDS packaged with a hazardous chemi-
cal, be sure to replace the appropriate MSDS in your files.

Obtaining the MSDS To obtain Material Safety Data Sheets (MSDSs) for any chemical prod-
uct supplied by Applied Biosystems or Ambion:

VI.C. Safety Information 33

 MessageAmp™ II aRNA Amplification Kit

• At www.appliedbiosystems.com, select Support, then MSDS.

Search by chemical name, product name, product part number, or
MSDS part number. Right-click to print or download the MSDS of
interest.
• At www.ambion.com, go to the web catalog page for the product of
interest. Click MSDS, then right-click to print or download.
• E-mail (MSDS_Inquiry_CCRM@appliedbiosystems.com), tele-
phone (650-554-2756; USA) or fax (650-554-2252; USA) your
request, specifying the catalog or part number(s) and the name of the
product(s). The associated MSDSs will be e-mailed unless you
request fax or postal delivery. Requests for postal delivery require 1
to 2 weeks for processing.
For the MSDSs of chemicals not distributed by Applied Biosystems or
Ambion, contact the chemical manufacturer.

C.II. Chemical alerts

General alerts for all Use with adequate ventilation. Avoid contact with eyes and skin. Read
chemicals the MSDS and follow the handling instructions. Wear appropriate pro-
tective eyewear, clothing, and gloves.

Specific chemical alerts

WARNING
CHEMICAL HAZARD. 10X First Strand Buffer is harmful if swallowed
or inhaled. Causes irritation to skin, eyes, gastrointestinal tract and respira-
tory tract. Do not taste or swallow. Avoid breathing vapor.

WARNING
CHEMICAL HAZARD. 10X Second Strand Buffer is harmful if swal-
lowed or inhaled. Causes irritation to skin, eyes, gastrointestinal tract and
respiratory tract. Do not taste or swallow. Avoid breathing vapor.

WARNING
CHEMICAL HAZARD. 10X T7 Reaction Buffer is harmful if swallowed
or inhaled. Causes irritation to skin, eyes, gastrointestinal tract and respira-
tory tract. Do not taste or swallow. Avoid breathing vapor.

WARNING
CHEMICAL HAZARD. aRNA Binding Buffer is harmful if inhaled, if
absorbed through the skin and if swallowed. Causes eye, skin, and respira-
tory tract irritation. Do not taste or swallow. Avoid breathing vapor. Contact
with acids or bleach liberates toxic gases. DO NOT ADD acids or bleach to
any liquid wastes containing cDNA binding buffer.

34 VI.C.II. Chemical alerts

 Appendix

WARNING
CHEMICAL HAZARD. Array Script may cause eye, skin, and respiratory
tract irritation. May be harmful if swallowed. Avoid breathing vapor.

WARNING
CHEMICAL HAZARD. cDNA Binding Buffer is harmful if inhaled, if
absorbed through the skin and if swallowed. Causes eye, skin, and respira-
tory tract irritation. Do not taste or swallow. Avoid breathing vapor. Contact
with acids or bleach liberates toxic gases. DO NOT ADD acids or bleach to
any liquid wastes containing cDNA binding buffer.

WARNING
CHEMICAL HAZARD. DNA Polymerase may cause eye, skin, and
respiratory tract irritation. May be harmful if swallowed. Avoid breathing
vapor.

WARNING
CHEMICAL HAZARD. RNase H may cause eye, skin, and respiratory
tract irritation. May be harmful if swallowed. Avoid breathing vapor.

WARNING
CHEMICAL HAZARD. RNase Inhibitor may cause eye, skin, and respi-
ratory tract irritation. May be harmful if swallowed. Avoid breathing vapor.

WARNING
CHEMICAL HAZARD. T7 Enzyme Mix may cause eye, skin, and respira-
tory tract irritation. May be harmful if swallowed. Avoid breathing vapor.

VI.C.II. Chemical alerts 35

 MessageAmp™ II aRNA Amplification Kit

36 VI.C.II. Chemical alerts